We found that in patients with glioma, B7‐H3, LAG3 and TIM3 were significantly raised, while the expression of PD‐L1, BTLA, TIGIT, PD‐1 and CTLA4 did not seem to be significantly different from those of normal individuals (Figure 4B). The gene discussed is CTLA4; the disease is central nervous system cancer.